Phase I Study of Indibulin in Combination With Erlotinib in Advanced Solid Tumors

Clinical trial NCT00591383 · UNKNOWN

Trial details

NCT number: NCT00591383
Sponsor: Alaunos Therapeutics
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumors

Start date: 2008-01-01
Primary completion: 2013-06-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.